- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tattoo ink masquerades as lesions
Sailors and bikers aren't the only ones getting tattoos these days. As more and more "mainstream" women get tattoos, physicians are finding the ink from the tattoos can migrate to the lymph nodes and show up on screening mammograms.
Sailors and bikers aren't the only ones getting tattoos these days. As more and more "mainstream" women get tattoos, physicians are finding the ink from the tattoos can migrate to the lymph nodes and show up on screening mammograms.
Researchers at the Beth Israel Medical Center in New York City presented a case report in the September issue of the American Journal of Roentgenology describing a patient presenting with apparent calcifications in the axillary lymph node on a screening mammogram.
The patient, a 35-year-old woman, was obtaining a baseline mammogram. She had extensive tattoos over her shoulders, arms, and back and had a mother who had been diagnosed with breast cancer when she was 55 years old.
After a bilateral mammogram, physicians detected a foci of calcification density around the right axillary lymph node. After fine-needle aspiration, pathologists determined that tattoo ink had been the true culprit behind the mammographic findings.
The researchers note that at least 30 different pigments are commercially available, each with varying levels of metallic ions. Tattoo artists will mix different inks to achieve subtle variations in shades and colors, making it difficult to determine which tattoos will lead to abnormal mammograms.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
